News

2019

Today’s health problems are tomorrow’s health crisesAxios

Boehringer builds out NASH pipeline with up to $870M deal with South Korea’s Yuhan | Endpoints News

Emricasan fails to meet primary endpoint in NASH-cirrhosis trial | Healio Hepatology

ENDRA Life Sciences and Rocky Vista University College of Osteopathic Medicine Partnering for Clinical Study of Thermo Acoustic Enhanced Ultrasound Device | AccessWire

Zydus completes enrollment in trial of Lipaglyn for NAFLD, NASH | Healio Hepatology

Fatty liver disease strikes Latino children like a ‘silent tsunami’ | USA Today

Gilead, Novo Nordisk Announce Intent to Initiate Clinical Collaboration | Gilead Sciences

Obesity Plagues Hispanics And Blacks In Colorado, Nation’s ‘Healthiest’ State | Kaiser Health News

Obesity Epidemic Leads To A New Problem — And It Could Be Worth Billions | Investor’s Business Daily

 

2018

Risks for Most Cancers Higher with NAFLD | Medpage Today

Fatty liver expert: ‘We face a moral, ethical and medical imperative’ | Healio

Multiple Drugs Advance for Fatty Liver Disease | Medscape

Pfizer, Novartis tie up to target NASH in crowded field | Endpoints News

More than 1 in 3 adults eat fast food on a given day, CDC survey finds | Brett Molina, USA TODAY

2017

More than 1 in 3 adults eat fast food on a given day, CDC survey finds | Scott Harris, MedPage Today

German Researchers Propose New Lifestyle Intervention for NASH | Universität Mainz

Pipeline Review for NASH Drugs, July 2017 | ReportLinker

One Third of HIV/AIDS Patients Have NASH | Michael Carter, NAM

NASH Now Affecting 16 Million Americans | Lydia Ramsey, Business Insider

Allergan Extending R&D Pipeline to Include NASH | Zacks Equity Research, Nasdaq

Companies Race to Find NASH Cure | Anne Steele, Fox Business

J&J Launches Partnerships for NASH, RA, obesity | Chris Lieu, Biocentury

NASH drug development halted | Genetic Engineering & Biotechnology News

Viking Announces Promising Top Line Results for NASH | PR Newswire

miRNA Signatures Can Identify NASH Patients | Gastroenterology & Endoscopy News

Can-Fite Establishes Clinical Advisory Board for NASH | PR Newswire

Exercise Improves Fatty Liver Disease | Medical News Bulletin

Interview on Push for NASH Treatment Options | Investorideas.com

Albireo Wins 2 U.S. Patents to Treat NASH | Daniela Semedo, PhD., Liver Disease News

NASH market to increase forty-fold by 2026 | Juliet Preston, MedCity News

Inflammatory signature of nonalcoholic fatty liver disease | ScienceDaily

Early Study to Test Bioelectronic Treatment for NASH | Ines Martins, PhD., Liver Disease News

What is NASH?

Do you have questions or are you looking for more information?

NASH Facts

Resources

Keep informed with industry related news and publications.

NASH Prevention | News | Publications | Clinical Trials

About NASH Alliance

Learn more about our clinical advisory team of experts.

Learn More

Subscribe To Our Mailing List